Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
15.69
-0.11 (-0.70%)
Mar 31, 2025, 2:33 PM EDT - Market open
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $850.92 million as of March 31, 2025. Its market cap has decreased by -32.68% in one year.
Market Cap
850.92M
Enterprise Value
498.73M
1-Year Change
-32.68%
Ranking
Category
Stock Price
$15.69
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $850.92M, an increase of 33.62%. That is a compound annual growth rate of 7.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 856.88M | -17.58% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |